Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,292
Total Claims
$1.7M
Drug Cost
552
Beneficiaries
$3,154
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+24%
Opioid rate vs peers
2.8% vs 2.2% avg
+123%
Cost per patient vs peers
$3,154 vs $1,411 avg
+63%
Brand preference vs peers
17.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
314
Opioid Claims
$5,291
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,903 claims · $1.5M
Generic: 9,051 claims · $214K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 241 | $332K |
| Dulaglutide | 157 | $199K |
| Rifaximin | 30 | $97K |
| Sitagliptin Phosphate | 59 | $91K |
| Apixaban | 67 | $74K |
| Semaglutide | 38 | $61K |
| Liraglutide | 31 | $56K |
| Insulin Detemir | 42 | $50K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $50K |
| Rivaroxaban | 24 | $33K |
| Fluticasone Propionate | 70 | $32K |
| Insulin Detemir | 34 | $30K |
| Sacubitril/Valsartan | 17 | $25K |
| Varicella-Zoster Ge/As01b/Pf | 120 | $24K |
| Insulin Nph Hum/Reg Insulin Hm | 25 | $23K |
Prescribing Profile
Patient Profile
72
Avg Age
67%
Female
1.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About